Business UpdateMay 27, 2026, 04:03 PM
Ligand Pharma to Attend Stifel & Goldman Sachs Investor Conferences
AI Summary
Ligand Pharmaceuticals announced its senior management will participate in two upcoming investor conferences in June 2026. This includes one-on-one meetings with investors at the Stifel 2026 Boston Cross Sector 1x1 Conference on June 3, 2026. Additionally, management will participate in a fireside chat and one-on-one meetings at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026, in Miami.
Key Highlights
- Ligand management to attend Stifel 2026 Boston Cross Sector 1x1 Conference on June 3, 2026.
- Management will hold one-on-one meetings with investors in Boston.
- Ligand to participate in Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026.
- A fireside chat is scheduled for June 10 at 10:00 a.m. ET in Miami.
- One-on-one meetings with investors will follow the fireside chat.
Price Impact
More from LGND